Prevention of retinal ganglion cell swelling by systemic brimonidine in a rat experimental glaucoma model

Clinical and Experimental Ophthalmology

Volumn 39, Issue 8, 2011, Pages 799-807

  Pinar Sueiro, Sergio ^a,b   Urcola, Haritz ^b,c   Agurtzane Rivas, Miren ^b   Vecino, Elena ^b  

^a HOSPITAL DE CRUCES   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c HOSPITAL TXAGORRITXU   (Spain)

Author keywords

Brimonidine; Glaucoma; Neuroprotection; Retinal ganglion cell

Indexed keywords

BRIMONIDINE; PHOSPHATE BUFFERED SALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUTERIZATION; CELL DEATH; CELL SIZE; CELL SUBPOPULATION; CELL SURVIVAL; CELL SWELLING; CHEMICAL LABELING; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLAUCOMA; INTRAOCULAR PRESSURE; NEUROPROTECTION; NONHUMAN; OCULAR BLOOD VESSEL; RAT; RETINA GANGLION CELL; RETINA INJURY;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; CELL COUNT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; INJECTIONS, INTRAPERITONEAL; INTRAOCULAR PRESSURE; PAPILLEDEMA; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RETINAL GANGLION CELLS; TREATMENT OUTCOME;

EID: 80255133222     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2011.02573.x     Document Type: Article

References (24)

1. García-Valenzuela E, Shareef S, Walsh J, Sharma SC. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res 1995; 61: 33-44.
2. Shareef SR, García-Valenzuela E, Salierno A, Walsh J, Sharma SC. Chronic ocular hypertension following episcleral venous occlusion in rats. Exp Eye Res 1995; 61: 379-82.
3. Yoles E, Schwartz M. Potencial neuroprotective therapy for glaucomatous optic neuropathy. Surv Ophthalmol 1998; 42: 367-72.
4. Agarwal R, Gupta SK, Agarwal P, Saxena R, Agrawal SS. Current concepts in the pathophysiology of glaucoma. Indian J Ophthalmol 2009; 57: 257-66.
5. Hartwick ATE, Zhang X, Chauhan BC, Baldridge WH. Functional assessment of glutamate clearance mechanisms in a chronic rat glaucoma model using retinal ganglion cell calcium imaging. J Neurochem 2005; 94: 794-807.
6. Wansley S, Gabelt BT, Dahl DB etal. Vitreous glutamate concentration and axon loss in monkeys with experimental glaucoma. Arch Ophthalmol 2005; 123: 64-70.
7. Casson RJ. Possible role of excitotoxicity in the pathogenesis of glaucoma. Clin Experiment Ophthalmol 2006; 34: 54-63.
8. Ahmed FA, Hegazy K, Chaudhary P, Sharma SC. Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increase intraocular pressure. Brain Res 2001; 913: 133-9.
9. Hernández M, Urcola JH, Vecino E. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments. Exp Eye Res 2008; 10: 798-806.
10. Kalapesi FB, Coroneo MT, Hill MA. Human ganglion cells express the alpha-2 adrenergic receptor: relevance to neuroprotection. Br J Ophthalmol 2005; 89: 758-63.
11. Wheeler LA, Gil D, Woldemussie E. Role of α2-adrenergic receptors in neuroprotection and glaucoma. Surv Ophthalmol 2001; 45: 290-4.
12. Woldemussie E, Ruiz G, Wijono M, Wheeler LA. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest Ophthalmol Vis Sci 2001; 42: 2849-55.
13. Lafuente MP, Villegas-Pérez MP, Mayor S, Aguilera ME, Miralles del Imperial J, Vidal-Sanz M. Neuroprotective effects of brimonidine against transient ischemic-induced retinal ganglion cell death. A close response in vivo study. Exp Eye Res 2002; 74: 181-9.
14. Acheampong A, Shackleton M, John B, Burke J, Wheeler L, Tang-Liu D. Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes. Drug Metab Dispos 2002; 30: 421-9.
15. Inglefield JR, Schwartz-Bloom RD. Activation of excitatory amino acid receptors in the rat hippocampal slice increases intracellular Cl and cell volume. J Neurochem 1998; 71: 1396-404.
16. Ruíz-Ederra J, García M, Martín F etal. Comparación de tres métodos de inducción del incremento crónico de la presión intraocular en el cerdo (glaucoma experimental). Arch Soc Esp Oftalmol 2005; 80: 571-80.
17. Ruíz-Ederra J, García M, Hernández M etal. The pig eye as a novel model of glaucoma. Exp Eye Res 2005; 81: 561-9.
18. Urcola JH, Hernández M, Vecino E. Three experimental glaucoma models in rats: comparison of the effects of intraocular pressure elevation on retinal ganglion cell size and death. Exp Eye Res 2006; 83: 429-37.
19. Toris CB, Gleason ML, Camras CB, Yablonski ME. Effects of brimonidine on aqueous humor dynamics in human eyes. Arch Ophthalmol 1995; 113: 1514-7.
20. Olney JW. Glutamate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion. J Neuropathol Exp Neurol 1969; 28: 455-74.
21. ++ signals at the inner plexiform layer of the rat retina. Invest Ophthalmol Vis Sci 2007; 48: 1410-5.
22. Wheeler LA, Woldemussie E, Lai R. Role of alpha-2 adrenergic receptor agonists in neuroprotection. Eur J Ophthalmol 2003; 11: 30-5.
23. Lai RK, Chun T, Hasson D, Lee S, Mehrbod F, Wheeler L. Alpha-2 adrenoceptor agonist protects retinal function after acute retinal ischemic injury in the rat. Vis Neurosci 2002; 19: 175-85.
24. Dong CJ, Guo Y, Agey P, Wheeler L, Hare WA. Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity. Invest Ophthalmol Vis Sci 2008; 49: 4515-22.